Department of MRI, Cangzhou Central Hospital, No. 16 Xinhua West Road, Yunhe District, 061001 Cangzhou, Hebei, China.
Department of MRI, Cangzhou Central Hospital, No. 16 Xinhua West Road, Yunhe District, 061001 Cangzhou, Hebei, China.
Rev Neurol (Paris). 2022 Apr;178(4):370-376. doi: 10.1016/j.neurol.2021.06.008. Epub 2021 Sep 28.
To investigate the efficacy of resistance exercise on symptoms of vestibular migraine (VM) among migraine patients, a total of 385 VM patients were recruited, among whom 312 were eligible to participate in the current study. Patients were randomly allocated into either resistance exercise or relaxation control groups, and received respective interventions two times per week for 12 weeks. Patients were followed up at two and four months, respectively, to evaluate treatment effects. Primary outcomes included Dizziness Handicap Inventory (DHI), the number of vertiginous attacks in the previous week and Vertigo Severity Scale (VSS). Secondary endpoints included depression and anxiety symptoms, which were measured using the scores of the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory (BDI). Serum concentrations of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), were also assessed. Resistance exercise was slightly more pronounced in alleviating VM symptoms than relaxation control at two-month follow-up. While at four-month follow-up, the extents of the symptom attenuation were obviously better in the resistance exercise group than the relaxation control, in terms of VSS and DHI scores, as well as BDI and BAI scores. Serum levels of both TNF-α and IFN-γ were also significantly lower in patients in the resistance group than those in the relaxation control group. Our study favors an exercise-oriented treatment scheme in rehabilitating therapy for patients suffering from VM, and sheds light on the molecular mechanism potentially involving TNF-α and IFN-γ related inflammation pathways.
为了研究抗阻运动对偏头痛性眩晕(VM)患者症状的疗效,共招募了 385 例 VM 患者,其中 312 例符合纳入标准参加本研究。患者被随机分配到抗阻运动组或放松对照组,每周接受两次治疗,共 12 周。分别在 2 个月和 4 个月时进行随访,以评估治疗效果。主要结局指标包括眩晕残障程度评定量表(DHI)、前一周眩晕发作次数和眩晕严重程度量表(VSS)。次要终点包括抑郁和焦虑症状,分别采用贝克焦虑量表(BAI)和贝克抑郁量表(BDI)评分进行评估。还评估了促炎细胞因子(包括肿瘤坏死因子-α[TNF-α]和干扰素-γ[IFN-γ])的血清浓度。与放松对照组相比,抗阻运动在 2 个月随访时对 VM 症状的缓解作用略明显。而在 4 个月随访时,与放松对照组相比,抗阻运动组的 VSS 和 DHI 评分、BDI 和 BAI 评分以及症状缓解程度明显更好。与放松对照组相比,抗阻运动组的 TNF-α 和 IFN-γ 血清水平也明显降低。我们的研究支持将运动导向的治疗方案作为 VM 患者康复治疗的一种选择,并提示了可能涉及 TNF-α和 IFN-γ相关炎症途径的分子机制。